Save your place

Sign in to WhoBought

Please try again later.

Harmony Biosciences Holdings, Inc. (HRMY) institutional ownership

Latest close $36.84 Jul 21, 2026
Market cap$2.0B 52-week range SectorHealthcare
Funds holding · Q1 2026
314
reported HRMY position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net bought $181M
168 buyers · 146 sellers

Harmony Biosciences Holdings, Inc. (HRMY) price and institutional activity

Dates

Q1 2026

$367M bought by 168 investors
Armistice Capital, LLC$37MSG Americas Securities, LLC$35M +166 more
$187M sold by 146 investors
Boston Partners-$22M683 Capital Management, LLC-$14M +144 more
Bought Sold Totals per quarter; hover a bar for the names.

Harmony Biosciences Holdings, Inc. (HRMY) institutional activity · 314

Investor Type Est. change Change Δ Own Date
Armistice Capital, LLC · Added +$37M
Change +1.1M Date Q1 2026
Armistice Capital, LLC Added· Q1 2026 +$37M +1.1M Q1 2026
SG Americas Securities, LLC · Added +$35M
Change +1.1M Date Q1 2026
SG Americas Securities, LLC Added· Q1 2026 +$35M +1.1M Q1 2026
Millennium Management LLC · Added +$24M
Change +723K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +$24M +723K Q1 2026
Goldman Sachs Group Inc · Added +$22M
Change +670K Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +$22M +670K Q1 2026
Boston Partners · Reduced −$22M
Change −666K Date Q1 2026
Boston Partners Reduced· Q1 2026 −$22M −666K Q1 2026
JPMorgan Chase & Co · Added +$20M
Change +624K Date Q1 2026
JPMorgan Chase & Co Added· Q1 2026 +$20M +624K Q1 2026
Two Sigma Investments, LP · Added +$17M
Change +526K Δ Own +254.4% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +$17M +526K +254.4% Q1 2026
683 Capital Management, LLC · Exited −$14M
Change −415K Δ Own −100.0% Date Q1 2026
683 Capital Management, LLC Exited· Q1 2026 −$14M −415K −100.0% Q1 2026
Lsv Asset Management · Added +$12M
Change +368K Date Q1 2026
Lsv Asset Management Added· Q1 2026 +$12M +368K Q1 2026
Vanguard · Added +$12M
Change +364K Date Q1 2026
Vanguard Added· Q1 2026 +$12M +364K Q1 2026
Qube Research & Technologies Ltd · Added +$10M
Change +315K Date Q1 2026
Qube Research & Technologies Ltd Added· Q1 2026 +$10M +315K Q1 2026
Janus Henderson Group PLC · Reduced −$10M
Change −306K Date Q1 2026
Janus Henderson Group PLC Reduced· Q1 2026 −$10M −306K Q1 2026
Trexquant Investment LP · Added +$9.7M
Change +295K Date Q1 2026
Trexquant Investment LP Added· Q1 2026 +$9.7M +295K Q1 2026
Pacer Advisors, Inc. · Exited −$9.5M
Change −290K Δ Own −100.0% Date Q1 2026
Pacer Advisors, Inc. Exited· Q1 2026 −$9.5M −290K −100.0% Q1 2026
Tang Capital Management LLC · Exited −$9.5M
Change −290K Δ Own −100.0% Date Q1 2026
Tang Capital Management LLC Exited· Q1 2026 −$9.5M −290K −100.0% Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 314

Famous investor activity in Harmony Biosciences Holdings, Inc. (HRMY)

Harmony Biosciences Holdings, Inc. (HRMY) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Germano Geno J. · Director Grant (A) 21K
Owned 21K Trade date May 14, 2026 Filed date May 18, 2026
Germano Geno J. Director Grant (A) 21K 21K May 14, 2026 May 18, 2026
Szyper Linda M. · Director Grant (A) 22K
Owned 22K Trade date May 14, 2026 Filed date May 18, 2026
Szyper Linda M. Director Grant (A) 22K 22K May 14, 2026 May 18, 2026
Philip Ron M. · Director Grant (A) 22K
Owned 22K Trade date May 14, 2026 Filed date May 18, 2026
Philip Ron M. Director Grant (A) 22K 22K May 14, 2026 May 18, 2026
Graf R. Mark · Director Grant (A) 22K
Owned 22K Trade date May 14, 2026 Filed date May 18, 2026
Graf R. Mark Director Grant (A) 22K 22K May 14, 2026 May 18, 2026
Sabater Juan A. · Director Grant (A) 22K
Owned 22K Trade date May 14, 2026 Filed date May 18, 2026
Sabater Juan A. Director Grant (A) 22K 22K May 14, 2026 May 18, 2026
Sender Gary · Director Grant (A) 22K
Owned 22K Trade date May 14, 2026 Filed date May 18, 2026
Sender Gary Director Grant (A) 22K 22K May 14, 2026 May 18, 2026
Budur Kumar · Officer 2 operations 0
Owned 38K Trade date May 1, 2026 Filed date May 18, 2026
Budur Kumar Officer 2 operations 0 38K May 1, 2026 May 18, 2026
Budur Kumar · Officer Tax withholding or exercise payment (F) -$283K
Price $31.83 Qty -9K Owned 24K Trade date May 1, 2026 Filed date May 18, 2026
Budur Kumar Officer Tax withholding or exercise payment (F) $31.83 -9K -$283K 24K May 1, 2026 May 18, 2026
Reicin Glenn · CFO Grant (A) 164K
Owned 164K Trade date Apr 14, 2026 Filed date May 18, 2026
Reicin Glenn CFO Grant (A) 164K 164K Apr 14, 2026 May 18, 2026
Zaeske Adam H. · Officer 2 operations 0
Owned 8K Trade date Apr 7, 2026 Filed date Apr 9, 2026
Zaeske Adam H. Officer 2 operations 0 8K Apr 7, 2026 Apr 9, 2026
Zaeske Adam H. · Officer Tax withholding or exercise payment (F) -$88K
Price $27.62 Qty -3K Owned 4K Trade date Apr 7, 2026 Filed date Apr 9, 2026
Zaeske Adam H. Officer Tax withholding or exercise payment (F) $27.62 -3K -$88K 4K Apr 7, 2026 Apr 9, 2026
Anastasiou Peter · Officer Grant (A) 212K
Owned 212K Trade date Apr 2, 2026 Filed date Apr 6, 2026
Anastasiou Peter Officer Grant (A) 212K 212K Apr 2, 2026 Apr 6, 2026
Ignelzi Troy A. · Director Grant (A) 18K
Owned 18K Trade date Apr 2, 2026 Filed date Apr 6, 2026
Ignelzi Troy A. Director Grant (A) 18K 18K Apr 2, 2026 Apr 6, 2026
Kapadia Sandip · Officer Sell −$139K
Price $37.15 Qty −4K Owned 25K Trade date Jan 26, 2026 Filed date Jan 28, 2026
Kapadia Sandip Officer Sell $37.15 −4K −$139K 25K Jan 26, 2026 Jan 28, 2026
Kapadia Sandip · Officer 2 operations 0
Owned 14K Trade date Jan 25, 2026 Filed date Jan 26, 2026
Kapadia Sandip Officer 2 operations 0 14K Jan 25, 2026 Jan 26, 2026
15 of 45
15 of 45 Sign in to continue to older insider transactions.

Harmony Biosciences Holdings, Inc. (HRMY) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Valor IV Pharma Holdings, LLC 11.2M
% of shares outstanding 19.2% Filing date Feb 13, 2024
Valor IV Pharma Holdings, LLC 11.2M 19.2% Feb 13, 2024
BlackRock Inc. 6.0M
% of shares outstanding 10.2% Filing date Jan 24, 2024
BlackRock Inc. 6.0M 10.2% Jan 24, 2024
FMR LLC 5.3M
% of shares outstanding 9.0% Filing date Feb 9, 2024
FMR LLC 5.3M 9.0% Feb 9, 2024
Vanguard Group Inc 3.7M
% of shares outstanding 6.3% Filing date Feb 13, 2024
Vanguard Group Inc 3.7M 6.3% Feb 13, 2024
Venbio Global Strategic Fund II L.P. 2.7M
% of shares outstanding 4.7% Filing date Feb 14, 2022
Venbio Global Strategic Fund II L.P. 2.7M 4.7% Feb 14, 2022
Vivo Capital Viii, LLC 2.6M
% of shares outstanding 4.3% Filing date Feb 14, 2023
Vivo Capital Viii, LLC 2.6M 4.3% Feb 14, 2023
Novo Holdings A 2.4M
% of shares outstanding 4.2% Filing date May 21, 2021
Novo Holdings A 2.4M 4.2% May 21, 2021
Hbm Healthcare Investments (cayman) Ltd. 2.1M
% of shares outstanding 3.6% Filing date Feb 14, 2023
Hbm Healthcare Investments (cayman) Ltd. 2.1M 3.6% Feb 14, 2023
8 of 8

Harmony Biosciences Holdings, Inc. (HRMY) ownership FAQ

Who owns HRMY?

314 reporting institutions disclosed HRMY position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.